Syringe News and Research

RSS

Intramuscular midazolam effective in treating status epilepticus

Drug delivery directly into muscle using an autoinjector is faster and may be more effective in stopping prolonged seizures, according to a study sponsored by the National Institutes of Health and conducted by a Wayne State University School of Medicine researcher.

17 Feb 2012

Rapid intramuscular injection of midazolam drug is safe, effective for status epilepticus

When a person is experiencing a prolonged convulsive seizure, quick medical intervention is critical. With every passing minute, the seizure becomes harder to stop, and can place the patient at risk of brain damage and death. This is why paramedics are trained to administer anticonvulsive medications as soon as possible -- traditionally giving them intravenously before arriving at the hospital.

16 Feb 2012

Obama's budget demonstrates his strong commitment to end HIV

"The budget President Obama outlined today yet again demonstrates his strong commitment to ending HIV by increasing funding for prevention and lifesaving care and treatment for those who cannot afford it in the United States," commented Carl Schmid, Deputy Executive Director of The AIDS Institute.

13 Feb 2012

Elton John AIDS Foundation awards over $3.2 million in new grants

The Elton John AIDS Foundation (EJAF) today announced over $3.2 million in new grants that will further its mission to assist the most marginalized populations vulnerable to HIV infection. These new awards brought EJAF's final total grant-making commitments for calendar 2011 to a record $8,316,871, with disbursements totaling $7,006,871 last year.

13 Feb 2012

Debate continues over needle/syringe exchange programs

Matt Fisher, a research assistant at the Center for Strategic & International Studies' Global Health Policy Center, summarizes the ongoing debate in Congress over needle and syringe exchange programs (NSEPs) in this post on the SmartGlobalHealth.org blog.

8 Feb 2012

Cytori's ADRCs safe and feasible for patients with AMI

Cytori Therapeutics announced today the publication of previously reported six-month outcomes from APOLLO, the Company's European clinical trial evaluating adipose-derived stem and regenerative cells (ADRCs) in patients with acute myocardial infarction, as Research Correspondence in the Journal of the American College of Cardiology.

25 Jan 2012

FzioMed's DYNAVISC adhesion barrier gel receives European CE Mark approval

FzioMed, Inc. is pleased to announce that it has received CE Mark approval to market DYNAVISC adhesion barrier gel in Europe for tendon and peripheral nerve surgery.

23 Jan 2012

Congress cuts federal funding for needle exchanges

Media outlets report on several public health issues, including a renewed funding ban on needle exchanges and a call for recalling a stent system.

23 Dec 2011

First Edition: December 22, 2011

Today's early morning highlights from the major news organizations, including articles on the Capitol Hill stalemate that threatens to cut Medicare payments to doctors and government efforts to keep details of a research experiment on bird flu secret.

22 Dec 2011

Study reveals previously unseen details of SBP8a anthrax bacteriophage

A new study has shown previously unseen details of an anthrax bacteriophage - a virus that infects anthrax bacteria - revealing for the first time how it infects its host, and providing an initial blueprint for how the phage might someday be modified into a tool for the detection and destruction of anthrax and other potential bioterror agents.

6 Dec 2011

Most healthcare workers do not believe that syringe needlestick injuries have been eliminated

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, surveyed 262 healthcare professionals at the APIC 2011 Annual Educational Conference held in June 2011.

5 Dec 2011

FDA issues draft guidance on artificial pancreas system

The U.S. Food and Drug Administration today issued draft guidance designed to help investigators and manufacturers as they develop and seek approval for artificial pancreas device systems to treat type 1 diabetes.

2 Dec 2011

CT scans appear to help in diagnosis of gout

According to research presented at the Nov 2011, American College of Rheumatology Annual Scientific Meeting in Chicago, a type of computed tomography scanning (commonly called CT scans) appears to help in the diagnosis of gout by detecting the urate crystals that are often a symptom of the disease.

7 Nov 2011

Pall launches new Acrodisc MS syringe filter

Pall Corporation, today introduced the Pall Acrodisc MS Syringe Filter the first syringe filter certified for low extractables in high performance liquid chromatography/mass spectrometry (LCMS) applications.

From Pall Corporation 5 Nov 2011

NYUCN to study 'Test and Linkage to Care Among Injecting Drug Users Kenya'

New York University College of Nursing (NYUCN) received a five-year, $4,161,665.00 grant from the National Institute of Health's National Institute on Drug Abuse (NIH/NIDA) to research "Test and Linkage to Care Among Injecting Drug Users (TLC_IDU) Kenya."

29 Oct 2011

Tanzania becomes first country to use self-destructing syringes; designer hopes others will follow suit

"Tanzania is to become the first country in the world to move exclusively to using syringes that self-destruct after a British entrepreneur played the health minister undercover footage of children being injected with used needles," the Guardian reports.

29 Oct 2011

Geron announces data from ongoing GRNOPC1 Phase 1 trial on spinal cord injury

Geron Corporation today announced two presentations on the company's ongoing Phase 1 clinical trial of its human embryonic stem cell-based therapy, GRNOPC1, in patients with spinal cord injury.

21 Oct 2011

FDA clears Cardium's new Excellagen topical gel for diabetic foot ulcers

Cardium Therapeutics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds.

11 Oct 2011

Cardium's Excellagen topical gel for diabetic foot ulcers receives FDA 510(k) clearance

Cardium Therapeutics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen™ professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds.

10 Oct 2011

Simple low-cost method for isolation and collection of fragile prostate cancer cells

At the Oct. 2-6 microTAS 2011 conference, the premier international event for reporting research in microfluidics, nanotechnology and detection technologies for life science and chemistry, University of Cincinnati researchers will present a simple, low-cost, method for separating and safely collecting concentrated volumes of fragile prostate cancer cells.

29 Sep 2011